Mediclinic Group is aware of a fake social media post that is being circulated requesting users to engage with a Medical Feedback Reward Survey. Mediclinic has not circulated any such survey. The social media post has not been published by Mediclinic. Mediclinic advises that people do not engage with the survey or respond. We release all our official communications on our website and our official social media channels which are listed on the website’s footer.
Intensive diabetes management, including insulin pump therapy and continuous glucose sensors (glucose monitoring) in both type 1 and type 2 diabetes
Obesity and weight management, metabolic disorders, effects of bariatric surgery on the endocrine system, nutrition, lipid disorders, diet and exercise counselling
Thyroid dysfunction, autoimmune polyglandular syndromes, thyroid nodules and thyroid cancer
Disorders of calcium metabolism, parathyroid disorders
Pituitary and adrenal disorders
Endocrine hypertension, resistant hypertension
Reproductive endocrinology (polycystic ovary syndrome, primary ovarian insufficiency, ovarian failure, amenorrhea, hirsutism), male and female hypogonadism
Endocrine conditions in pregnancy
Metabolic bone diseases (osteopenia and osteoporosis), vitamin D and calcium metabolism
Hypoglycemic disorders and neuroendocrine tumours.
Profile
Nationality
UK
Summary
Dr Ahmed Al-Sharefi is a fellow of the Royal College of Physicians of London and a member of Royal College of Physicians of Edinburgh in the UK and has completed his post graduate training (CCT in Endocrinology, Diabetes and General Internal Medicine) from the North east of England-UK. He is SCOPE certified bariatrician from the World Obesity Federation .
Dr Ahmed Al-Sharefi has 15 years of experience working in different institutions in the UK and UAE with a special interest in obesity management, Andrology and the application of technology in the management of diabetes including insulin pumps and closed loop systems (also known as Artificial Pancreas).
Throughout his career, he has gained invaluable clinical experience working in different NHS hospitals in the UK including a research placement at Imperial College London and Hammersmith Hospital in London in 2019. He published numerous scientific papers in peer-reviewed journals, including a book chapter on diabetes and lipids published by Oxford University Press. He also presented his work in several national and international conferences.
Dr Al-Sharefi contributes to the development of national diabetes guidelines as a member of the Joint British Diabetes Society for Inpatient Care Group (JBDS-IP). Moreover, his outstanding achievements have been acknowledged through various awards, including the undergraduate top 10 students award, the Kelly-Young regional prize, best oral presentation prize 2016 and best poster prize in obesity update conference 2017.
Aside from his clinical and research endeavours, Dr Al-Sharefi is an examiner for the Royal College MRCP PACES exam and is regularly involved in teaching endocrinology courses on a national level, demonstrating his commitment to the education and mentorship of future physicians.
Qualification
FRCP (London.) , MRCP ( Edinburgh) , UK CCT (Endocrinology, Diabetes and General Internal Medicine), SCE ( endocrinology), SCOPE certified
